Circulate Health, a California-based precision therapeutic plasma exchange company, has received a new seven-figure strategic investment from global venture capital firm Scrum Ventures. The funding is expected to support the company’s continued expansion as therapeutic plasma exchange gains broader consumer adoption in search of science-backed longevity and detoxification treatments.
The company develops technology designed to remove microplastics, environmental toxins, inflammatory markers, and other microscopic pollutants from the bloodstream. Early research cited by Circulate Health suggests that these contaminants may accumulate over time, driving systemic inflammation, oxidative stress, and long-term health concerns. With growing public attention on microplastic exposure and longevity medicine, the company is positioning itself as a leader in scalable, patient-centered TPE solutions.
Scrum Ventures, which invests across health, sports, mobility, and next-generation performance technologies, views Circulate Health as a pivotal player in the emerging longevity market. The partnership reflects the convergence of health optimization trends with advanced therapeutic platforms.
Circulate Health is backed by Khosla Ventures and is continuing to expand its research programs and clinical footprint. The company says the new partnership will help accelerate development and industry impact as interest in proactive, technology-enabled longevity care continues to rise.
KEY QUOTES
“We’re entering a new era where more and more consumers are recognizing the benefits of TPE. Partnering with Scrum Ventures allows us to expand our research and continue the momentum we’ve seen since inception.”
Brad Younggren, CEO and Co-Founder, Circulate Health
“The shift toward proactive, science backed longevity care is one of the most important movements in modern health. Circulate is positioned at the center of that transformation—they’re building the first truly scalable, patient centered platform in therapeutic plasma exchange.”
Michael Proman, Partner, Scrum Ventures
